-
RCCA Expands to Connecticut
Post on 1/17/17
-
Why Regeneron Pharmaceuticals, Inc. Stock Slipped 32.4% in 2016
Post on 1/17/17
-
Is Donald Trump Big Pharma's Worst Nightmare?
Post on 1/17/17
-
Trumpcare, Not Obamacare, Could Be a Job Killer
Post on 1/17/17
-
Does Johnson & Johnson Pass the Buffett Test?
Post on 1/17/17
-
Akers Biosciences Closes Public Offering
Post on 1/16/17
-
Retro Fitness Sprints Up Entrepreneur’s Franchise 500 List to No. 119
Post on 1/15/17
-
A Video Conversation with Dean Petkanas, CEO of Kannalife Sciences - Part V
Post on 1/26/17
-
A Video Conversation with Dean Petkanas, CEO of Kannalife Sciences - Part IV
Post on 1/25/17
-
A Video Conversation with Dean Petkanas, CEO of Kannalife Sciences - Part III
Post on 1/23/17
-
A Video Conversation with Dean Petkanas, CEO of Kannalife Sciences - Part II
Post on 1/19/17
-
A Video Conversation with Dean Petkanas, CEO of Kannalife Sciences - Part I
Post on 1/17/17
-
Aetna Launches $200m Vitality Re VIII Health Insurance Linked ILS
Post on 1/13/17
-
SPEAR Physical Therapy Voted Best Private Practice in the U.S. by APTA
Post on 1/12/17
-
3 Charts Every Bristol-Myers Squibb Shareholder Needs to See
Post on 1/12/17
-
Merck Muscles Into Bristol's Combo Space
Post on 1/12/17
-
Why Novartis Dropped 15.1% in 2016
Post on 1/12/17
-
Celgene Is On Its Way To $196
Post on 1/12/17
-
3 Surprises From Pfizer at the J. P. Morgan Healthcare Conference
Post on 1/12/17
-
Johnson & Johnson: Too Big To Break Up
Post on 1/11/17
-
Can Johnson & Johnson Upset Chevron In The Divisional Round?
Post on 1/11/17
-
Johnson & Johnson Stock Split: Coming in 2017?
Post on 1/11/17
-
1 Perfect Stock to Invest in the Pharmaceutical Industry
Post on 1/11/17
-
What's Next For Celgene
Post on 1/11/17
-
Why Celldex Therapeutics Imploded in 2016
Post on 1/10/17
New York
